Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Fighting the Placebo Effect in Fibromyalgia Drug Trials By Scott Millard June 23, 2017 Consulting Biomarker Trends: Advancing the Body’s Ability to Fight Cancer By Premier Research June 21, 2017 Clinical ResearchPhase 1 - Phase 4 Why Have Cancer Treatment Vaccines Fallen Short? By Premier Research June 15, 2017 Consulting 4 Obstacles to Collecting Quality Data in Psychiatric Drug Trials By Krista Armstrong June 13, 2017 Consulting Distinctive Characteristics of Fibromyalgia Patients By Scott Millard June 12, 2017 Consulting 4 Historical Orphan Drug Development Barriers, Have We Broken Through? By Juliet Moritz June 8, 2017 Previous 1 …44 45 46 47 48 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today